Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionPrudential Plc
Latest Disclosed Ownership169,077 shares
Latest Disclosed Value $ 23,564,261
Prudential Plc reports 2.48% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - Prudential Plc filed a 13F-HR form disclosing ownership of 169,077 shares of Gilead Sciences, Inc. (US:GILD) valued at $23,564,261 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 173,376 shares of Gilead Sciences, Inc.. This represents a change in shares of -2.48% during the quarter. The current value of the position is $21,809,242 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 169,077 -4,299 -2.48 23,564 10.73 0.1380
2026-02-11 2025-12-31 13F GILEAD SCIENCES COM 375558103 173,376 -9,442 -5.16 21,280 4.87 0.1687
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 182,818 -11,677 -6.00 20,293 -5.89 0.1491
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 194,495 -27,809 -12.51 21,564 -13.43 0.1300
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 222,304 -35,359 -13.72 24,909 4.66 0.1247
2025-02-13 2024-12-31 13F GILEAD SCIENCES COM 375558103 257,663 -23,341 -8.31 23,800 1.02 0.1197
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 281,004 -38,158 -11.96 23,559 7.59 0.1184
2024-08-07 2024-06-30 13F GILEAD SCIENCES COM 375558103 319,162 -32,218 -9.17 21,898 -14.92 0.1477
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 351,380 151,697 75.97 25,739 59.11 0.1961
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 199,683 -19,844 -9.04 16,176 -1.67 0.1641
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 219,527 14,657 7.15 16,451 4.19 0.1828
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 204,870 -7,754 -3.65 15,789 -10.50 0.1846
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 212,624 -13,385 -5.92 17,641 -9.08 0.2071
2023-02-09 2022-12-31 13F GILEAD SCIENCES COM 375558103 226,009 43,068 23.54 19,403 71.91 0.2436
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 182,941 -356 -0.19 11,286 -0.39 0.1786
2022-08-12 2022-06-30 13F GILEAD SCIENCES COM 375558103 183,297 -14,025 -7.11 11,330 -3.42 0.2051
2022-05-13 2022-03-31 13F GILEAD SCIENCES COM 375558103 197,322 141,640 254.37 11,731 190.16 0.1697
2022-02-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 55,682 29,534 112.95 4,043 121.41 0.0553
2021-11-10 2021-09-30 13F GILEAD SCIENCES COM 375558103 26,148 -106,353 -80.27 1,826 -79.99 0.0255
2021-08-13 2021-06-30 13F GILEAD SCIENCES GILEAD SCIENCES INC 375558103 132,501 -132,187 -49.94 9,124 -46.67 0.0846
2021-05-14 2021-03-31 13F Gilead Sciences Gilead Sciences Inc 375558103 264,688 264,688 17,107 0.1185
2020-10-30 2020-09-30 13F Gilead Sciences Gilead Sciences Inc 375558103 0 -1,863,101 -100.00 0 -100.00
2020-07-31 2020-06-30 13F Gilead Sciences Gilead Sciences Inc 375558103 1,863,101 430,760 30.07 143,347 33.87 0.6903
2020-05-01 2020-03-31 13F Gilead Sciences Gilead Sciences Inc 375558103 1,432,341 1,423,870 16,808.76 107,083 19,369.64 0.5709
2020-02-13 2019-12-31 13F GILEAD SCIENCES GILEAD SCIENCES INC 375558103 8,471 -2,689,085 -99.69 550 -99.68 0.0023
2019-11-12 2019-09-30 13F GILEAD SCIENCES COM 375558103 2,697,556 -128,775 -4.56 170,836 -10.62 0.5025
2019-10-04 2019-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 2,826,331 -296,067 -9.48 191,124 -5.84 0.5843
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM 375558103 2,826,331 -296,067 191,124
2019-10-04 2019-03-31 13F/A-1 Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 3,122,398 32,583 1.05 202,988 5.03 0.7309
2019-05-13 2019-03-31 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 3,122,398 32,583 202,988
2019-10-04 2018-12-31 13F/A-1 Gilead Sciences Gilead Sciences Inc 375558103 3,089,815 -199,735 -6.07 193,268 -23.91 0.7783
2019-02-13 2018-12-31 13F Gilead Sciences Gilead Sciences Inc 375558103 3,089,815 -199,735 193,268
2019-10-03 2018-09-30 13F/A-1 Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 3,289,550 -558,140 -14.51 253,986 -6.82 0.8197
2018-11-14 2018-09-30 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 3,289,550 -558,140 253,986
2018-08-14 2018-06-30 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 3,847,690 339,324 9.67 272,571 3.05 0.8529
2018-05-15 2018-03-31 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 3,508,366 103,039 3.03 264,496 8.42 0.8258
2018-02-14 2017-12-31 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 3,405,327 247,331 7.83 243,958 -4.65 0.7430
2017-11-14 2017-09-30 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 3,157,996 -367,171 -10.42 255,860 2.54 0.8073
2017-08-14 2017-06-30 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 3,525,167 168,200 5.01 249,512 9.43 0.8176
2017-05-15 2017-03-31 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 3,356,967 376,394 12.63 228,006 6.82 0.7642
2017-02-09 2016-12-31 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 2,980,573 684,104 29.79 213,439 17.47 0.7504
2016-11-14 2016-09-30 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 2,296,469 109,469 5.01 181,697 -0.41 0.6857
2016-08-09 2016-06-30 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 2,187,000 219,741 11.17 182,439 0.96 0.7160
2016-05-13 2016-03-31 13F Gilead Sciences Gilead Sciences Inc 375558103 1,967,259 -752 -0.04 180,712 -9.26 0.7330
2016-02-12 2015-12-31 13F Gilead Sciences Gilead Sciences Inc 375558103 1,968,011 64,800 3.40 199,143 6.56 0.8090
2015-11-13 2015-09-30 13F Gilead Sciences Gilead Sciences Inc 375558103 1,903,211 176,300 10.21 186,876 -7.57 0.7987
2015-08-14 2015-06-30 13F Gilead Sciences Gilead Sciences Inc 375558103 1,726,911 340,900 24.60 202,187 48.66 0.7719
2015-05-15 2015-03-31 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 1,386,011 -20,850 -1.48 136,010 2.56 0.6000
2015-02-13 2014-12-31 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 1,406,861 120,218 9.34 132,610 -3.18 0.5619
2014-11-14 2014-09-30 13F Gilead Sciences GILEAD SCIENCES ORD SHS 375558103 1,286,643 -100,650 -7.26 136,963 19.08 0.5666
2014-08-14 2014-06-30 13F Gilead Sciences Gilead Sciences Inc 375558103 1,387,293 827,500 147.82 115,020 189.96 0.4797
2014-05-15 2014-03-31 13F Gilead Sciences Gilead Sciences Inc 375558103 559,793 -13,600 -2.37 39,667 -7.94 0.1764
2014-02-14 2013-12-31 13F GILEAD SCIENCES COM 375558103 573,393 22,366 4.06 43,090 24.44 0.1846
2013-12-18 2013-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 551,027 275,700 100.14 34,626 145.59 0.1765
2013-11-15 2013-09-30 13F GILEAD SCIENCES COM 375558103 551,027 34,626
2013-08-15 2013-06-30 13F GILEAD SCIENCES COM 375558103 275,327 275,327 14,099 0.0763
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.